fbpx

Yellow fever – Togo

On 20 April 2020, WHO received information regarding a confirmed yellow fever case in Galangashie health area, located 30 km from Mango village, Oti district, Savanes region in the northern part of Togo.

The case is a 55-year-old woman with no vaccination history for yellow fever. She had onset of symptoms on 31 January 2020 and presented to a health facility on 3 February 2020 with fever and aches. The following day she developed jaundice and a blood sample was taken. On 7 February , the blood sample was transported to the national laboratory. On 10 February , the sample from the case was received at the national laboratory and test results on 17 March were Immunoglobulin M (IgM) positive for yellow fever. The positive yellow fever result was confirmed by the Institute Pasteur in Dakar Senegal, a yellow fever reference laboratory on 14 April 2020 by seroneutralisation. Syndicated from www.who.int - Click here to view original source

By | 2020-06-05T04:00:00+00:00 June 5th, 2020|COVID19|0 Comments

Measles – Burundi

Burundi has been experiencing an increase in the number of confirmed cases of measles since November 2019. This outbreak initially started in a refugee transit camp (Centre de transit de Cishemere, Cibitoke Health district), whose inhabitants had arrived from measles-affected provinces of the Democratic Republic of Congo. Refugees spend 21 days in the Transit Camp of Cishemere before they are sent to permanent camps in Nyankanda and Bwagiriza refugee camps in Butezi, Kavumu camp of Cankuzo, Garsowe camp of Muyinga and Mulumba camp at Kiremba.

The outbreak was identified when suspected measles cases had been reported by the local residents in the surrounding areas, highlighting pockets of under-vaccinated populations. According to WHO/UNICEF 2018 estimates, measles first dose vaccination coverage is relatively high (88%), and slightly lower for the second dose (77%). However, this does not reflect the vaccination coverage of incoming refugees. Syndicated from www.who.int - Click here to view original source

By | 2020-05-06T04:00:00+00:00 May 6th, 2020|COVID19|Comments Off on Measles – Burundi

Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia

From 1 through 31 March 2020, the National IHR Focal Point of Saudi Arabia reported 15 additional cases of MERS-CoV infection, including five associated deaths. The cases were reported from Riyadh (7 cases), Makkah (4 cases), Najran (3 cases), and Al Qassim (1 case) regions.

The link below provides details of the 15 reported cases. Syndicated from www.who.int - Click here to view original source

By | 2020-05-05T04:00:00+00:00 May 5th, 2020|COVID19|Comments Off on Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia

Measles – Mexico

Mexico is experiencing a measles outbreak. Between 1 January and 2 April 2020, 1,364 probable1cases of measles were reported, of which 124 were laboratory confirmed, 991 were discarded and 328 remain under investigation. The age of the confirmed measles cases ranged from three months to 68 years (median=20 years), and 59% were male. Analysis conducted by the National Reference Laboratory (InDRE) identified the genotype D8 (similar to other countries in the Region), linage MVs/GirSomnath.IND/42.16/ for 17 of the confirmed cases.

Of the 124 confirmed cases, 105 were in Mexico City, 18 in Mexico State, and one in Campeche State; the following is a summary of the epidemiological situation in each: Syndicated from www.who.int - Click here to view original source

By | 2020-04-24T04:00:00+00:00 April 24th, 2020|COVID19|Comments Off on Measles – Mexico

Yellow fever – Ethiopia

On 3 March 2020, the Ethiopian Public Health Institute (EPHI) reported three suspected yellow fever cases in Enor Ener Woreda, Gurage zone, SNNPR. The three reported cases were members of the same household (father, mother and son) located in a rural kebele. Two of three samples tested positive at national level by reverse transcriptase-polymerase chain reaction (RT-PCR) and were subsequently confirmed positive by plaque reduction neutralization testing (PRNT) at the regional reference laboratory, Uganda Viral Research Institute (UVRI) on 28 March 2020.

In response to the positive RT-PCR results, the EPHI and Ministry of Health performed an in-depth investigation and response, supported by partners including WHO. Syndicated from www.who.int - Click here to view original source

By | 2020-04-22T04:00:00+00:00 April 22nd, 2020|COVID19|Comments Off on Yellow fever – Ethiopia

Yellow fever – Republic of South Sudan

On 3 March 2020, a WHO supported cross-border rapid response investigation identified two presumptive positive cases of yellow fever in Kajo Keji county, Central Equatoria State, South Sudan. The initial Polymerase Chain Reaction (PCR) testing conducted at the National Public Health Laboratory in Juba, South Sudan tuned out negative. However, following further testing, both the cases were confirmed positive for yellow fever by plaque reduction neutralization testing (PRNT) at the regional reference laboratory, Uganda Viral Research Institute (UVRI) on 28 March.

The investigation was mounted in response to the recently declared outbreak in bordering Moyo district, Uganda. During the investigation, the team collected 41 blood samples from five villages which were in close proximity to the bordering Moyo district, Uganda. Of the 41 individuals whose samples were collected, nine (22%) had history of fever, but none had history of jaundice. The individuals represented a spectrum of occupations typical for the area (farming, forestry, homemaker, soldier). Most of the individuals investigated were between 20-45 years of age, and 18 (44%) of these individuals were female. Syndicated from www.who.int - Click here to view original source

By | 2020-04-18T04:00:00+00:00 April 18th, 2020|COVID19|Comments Off on Yellow fever – Republic of South Sudan
Yellow fever – Togo